Dr. Michael Guttman M.D.

Recommended Articles

• What Is Cachexia?

  Cachexia is a wasting syndrome, which is a process that causes fat tissues and muscle to waste away. This disorder causes involuntary weight loss, which often affects people with late-stage chronic diseases, such as cancer, renal disease, HIV or AIDS, and congestive heart failure.People with...

• What Are the Symptoms of Testicular Cancer?

  Testicular cancer is rare when compared to other forms of cancer. This cancer develops in one or both testicles in men, particularly among men in the between the ages of 20-years-old and 40-years-old. It may be seen in elderly men as well. In the past few decades, the number of people affected by...

• Natural Compound in Garlic May Help Fight Ovarian Cancer

  Dating all the way back to 5000 years ago, garlic has been used in food and as medicine, exhibiting nutritional and medicinal value. In fact, it was the Greek physician Hippocrates, also known as the “Father of Western Medicine”, who recommended the use of garlic for a variety of conditions and...

• Is it Lung Cancer or COPD?

  Chronic Obstructive Pulmonary Disease (COPD) and lung cancer are two ends of the same spectrum. Though vastly different in core characteristics, they share many symptoms such as painful wheezing, a persistent cough, and the production of copious mucus. Both these diseases have similar causes and...

• This Ovarian Cancer Treatment Gives Patients Freedom During Chemotherapy

  PARP inhibitors are making a big difference to cancer patients. Since they are administered orally, patients have the freedom to take them at home, and aren’t restricted by hospital visits for chemotherapy. Here’s Laurie McAndrews’s story.In December 2014, Laurie McAndrews from Illinois was...

• NHS Strikes Deal for Cutting Edge Cancer Treatment for Adults with Lymphoma

  The National Health Service (NHS) is the publicly-funded national healthcare system for England. Together with the biopharmaceutical company, Gilead Sciences, the two organizations have reached an agreement to provide CAR T-cell therapy to patients with a type of cancer that has, sadly, left them...